U.S. Markets open in 6 hrs 51 mins
  • S&P Futures

    4,145.75
    +15.25 (+0.37%)
     
  • Dow Futures

    34,111.00
    +116.00 (+0.34%)
     
  • Nasdaq Futures

    12,604.75
    +59.50 (+0.47%)
     
  • Russell 2000 Futures

    1,958.50
    +8.60 (+0.44%)
     
  • Crude Oil

    78.52
    +0.05 (+0.06%)
     
  • Gold

    1,892.50
    +1.80 (+0.10%)
     
  • Silver

    22.47
    +0.05 (+0.22%)
     
  • EUR/USD

    1.0740
    +0.0022 (+0.2041%)
     
  • 10-Yr Bond

    3.6530
    0.0000 (0.00%)
     
  • Vix

    19.63
    +0.97 (+5.20%)
     
  • GBP/USD

    1.2102
    +0.0032 (+0.2650%)
     
  • USD/JPY

    131.2080
    -0.1280 (-0.0975%)
     
  • BTC-USD

    22,683.83
    -532.38 (-2.29%)
     
  • CMC Crypto 200

    522.10
    -14.79 (-2.76%)
     
  • FTSE 100

    7,885.17
    +20.46 (+0.26%)
     
  • Nikkei 225

    27,584.35
    -22.11 (-0.08%)
     

Verve Therapeutics Crashes On The FDA's Long List Of Gene-Editing Concerns

Verve Therapeutics Crashes On The FDA's Long List Of Gene-Editing Concerns

The FDA has a bevy of safety concerns surrounding Verve's gene-editing approach to high cholesterol, leading VERV stock to crash Monday.